Metropolitan Life Insurance Company (MetLife)’s Purple Innovation PRPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-140
Closed -$5.99K 2380
2023
Q3
$5.99K Hold
140
﹤0.01% 2381
2023
Q2
$9.74K Hold
140
﹤0.01% 2310
2023
Q1
$9.25K Sell
140
-1
-0.7% -$112 ﹤0.01% 2189
2022
Q4
$16.9K Buy
+141
New +$15.4K ﹤0.01% 2097
2022
Q3
Sell
-25
Closed -$1.94K 2343
2022
Q2
$1.94K Sell
25
-119
-83% -$13.8K ﹤0.01% 2360
2022
Q1
$21.1K Sell
144
-404
-74% -$79.6K ﹤0.01% 2065
2021
Q4
$182K Sell
548
-27
-5% -$10.5K ﹤0.01% 2091
2021
Q3
$302K Buy
575
+19
+3% +$11.9K ﹤0.01% 1761
2021
Q2
$367K Buy
556
+196
+54% +$150K 0.01% 1716
2021
Q1
$285K Buy
360
+172
+91% +$149K ﹤0.01% 1780
2020
Q4
$155K Sell
188
-83
-31% -$60.5K ﹤0.01% 2114
2020
Q3
$168K Buy
271
+73
+37% +$38.8K ﹤0.01% 1884
2020
Q2
$89.2K Buy
+198
New +$62.4K ﹤0.01% 2322

Other funds holding PRPL

Metropolitan Life Insurance Company (MetLife)'s PRPL Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Purple Innovation (PRPL) in Q4 2023, closing a stake of 140 shares — an estimated $5.99K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PRPL in Q2 2020 and held it in 13 quarters. The position peaked at $367K in Q2 2021. 87 funds tracked by Wall St. Rank hold PRPL as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Purple Innovation position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 140 Purple Innovation shares in Q4 2023, an estimated $5.99K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Purple Innovation in Q2 2020 and held it in 13 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Purple Innovation position peaked at $367K in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Purple Innovation as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.